MedPath

湖北美宝药业股份有限公司

Ownership
-
Established
2001-08-06
Employees
-
Market Cap
-
Website
http://www.meibaoyaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

35

NMPA:35

Drug Approvals

小儿感冒颗粒

Approval Number
国药准字Z42020858
Approval Date
Sep 21, 2020
NMPA

大山楂颗粒

Approval Number
国药准字Z42021544
Approval Date
Sep 21, 2020
NMPA

牛黄解毒片

Approval Number
国药准字Z42020863
Approval Date
Sep 21, 2020
NMPA

复方丹参片

Approval Number
国药准字Z42020861
Approval Date
Sep 21, 2020
NMPA

板蓝根颗粒

Approval Number
国药准字Z42020854
Approval Date
Sep 21, 2020
NMPA

三七片

Approval Number
国药准字Z42020856
Approval Date
Sep 21, 2020
NMPA

五味子颗粒

Approval Number
国药准字Z42021779
Approval Date
Sep 21, 2020
NMPA

安络痛片

Approval Number
国药准字Z42021949
Approval Date
Sep 21, 2020
NMPA

生脉颗粒

Approval Number
国药准字Z42021548
Approval Date
Sep 21, 2020
NMPA

维C银翘片

Approval Number
国药准字Z42020857
Approval Date
Sep 21, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.